AMY SMITH: Open Payments
NPI 1952986127 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 43 payments from 15 companies in 2025. Trend: 2023 $808 · 2024 $1,941 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 16 | $228 |
| SCILEX PHARMACEUTICALS INC. | 8 | $138 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $51 |
| ABBVIE INC. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Saluda Medical Americas, Inc. | 2 | $39 |
| BIOTRONIK NRO, Inc. | 2 | $35 |
| MML US, Inc. | 1 | $30 |
| Averitas Pharma Inc. | 1 | $28 |
| Curonix LLC | 1 | $24 |
Products named: Belbuca, ZTLido, JOURNAVX, JEMPERLI, Evoke, Prospera, ReActiv8, QUTENZA.
Industry payments across MD — which companies pay providers there.
